| Structure |
Chemical Name |
CAS |
MF |
 |
5-Deshydroxymethyl-5-chloro Losartan (Losartan Impurity K) |
1159977-26-0 |
C21H20Cl2N6 |
 |
Paxlovid Impurity 16 |
|
|
 |
N-(3,5-ジメトイルアダマンタン-1-イル)ホルムアミド |
351329-88-9 |
C13H21NO |
 |
Lumateperone Impurity 3 |
313544-76-2 |
C17H21N3O3 |
 |
Ticagrelor Impurity 108 |
|
|
 |
ジフィリン O-グルコシド |
30021-77-3 |
C27H26O12 |
 |
Bepotastine N-Oxide Impurity |
|
|
 |
DANTROLENE RELATED COMPOUND B (5-(4ニトロフェニル)-2-フルアルデヒド-(2-カルボキシメチル)セミカルバゾン) |
57268-33-4 |
C14H12N4O6 |
 |
Aztreonam Impurity 2 |
|
|
 |
アトルバスタチンアセトニド |
581772-29-4 |
C36H39FN2O5 |
 |
Urapidil Impurity 18 |
|
|
 |
Sitagliptin N-Sulfate |
940002-57-3 |
C16H15F6N5O4S |
 |
SofosBuvir Impurity 50 |
|
|
 |
3-Pyridinecarboxylic acid, 6-(4-carboxy-1-piperidinyl)-5-chloro- |
958457-83-5 |
C12H13ClN2O4 |
 |
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
 |
Voriconazole Impurity 6 |
|
|
 |
3-Desoxyvitamin D3 |
69662-75-5 |
C27H44 |
 |
(E)-オロパタジン塩酸塩 |
949141-22-4 |
C21H24ClNO3 |
 |
Cefoxitin Impurity 4 |
|
|
 |
Strontium 88 |
14762-60-8 |
|
 |
Benzeneacetonitrile, 4-(4-chloro-1-oxobutyl)-α,α-dimethyl- |
169032-17-1 |
C14H16ClNO |
 |
Pramipexole DBTA Impurity |
1821389-09-6 |
C7H8N2S |
 |
4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl- |
2512216-37-2 |
C16H17N3O2 |
 |
Ciprofloxacin Related CoMpound |
528851-30-1 |
C15H17Cl2N3O3 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
![2-bromo-6-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/) |
2-bromo-6-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
|
|
 |
Revefenacin Impurity 7 |
1158777-54-8 |
C14H19ClN2O3 |
 |
(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine |
1867177-06-7 |
C9H13N3OS |
 |
アロエエモジングルコシド |
29010-56-8 |
C21H20O10 |
 |
4-DesMethoxy-4-broMo TriMethopriM |
16285-82-8 |
C13H15BrN4O2 |
 |
Merariveron impurity D |
|
C26H28N6O3S2 |
![Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-](/CAS/20210305/GIF/1431216-61-3.gif) |
Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)- |
1431216-61-3 |
C30H32F6N4O3 |
 |
Canagliflozin impurity H |
|
|
![Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-](/CAS/20150408/GIF/1255529-23-7.gif) |
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- |
1255529-23-7 |
C24H30ClN7O4S |
 |
DecitaBine Impurity 10 |
|
|
 |
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-(hydroxyMethyl)-1-(1H-1,2,4-triazol-1-yl)- |
160709-02-4 |
C14H15F2N3O2 |
 |
(R)-2-((2R,5R)-3,6-dioxo-5-phenylpiperazin-2-yl)-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
860011-30-9 |
C16H17N3O4S |
 |
(R)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-methoxyethyl)-8-hydroxyquinolin-2(1H)-one |
|
|
 |
1-Naphthaleneethanol,decahydro-2-hydroxy- 2,5,5,8a-tetramethyl-,(1R,2R,4aS,8aS)- |
38419-75-9 |
C16H30O2 |
 |
(R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C18H20FN5O2 |
 |
Canagliflozin Isomer Impurity 1 |
|
|
 |
(S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione |
148857-42-5 |
C11H10ClNO3 |
 |
Mupirocin EP Impurity A |
|
C26H44O9 |
 |
Posaconazole Impurity 33 |
182210-71-5 |
C12H13F2IO2 |
 |
(11β,16α)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione |
131918-72-4 |
C23H28O7 |
 |
MeropeneM iMpurity 5 |
|
|
 |
Dobutamine Impurity 16 |
|
|
![Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]-](/CAS/20150408/GIF/83881-53-2.gif) |
Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]- |
83881-53-2 |
C21H26N2O3 |
![5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI)](/CAS/20200515/GIF/639857-68-4.gif) |
5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI) |
639857-68-4 |
C14H13NO |
 |
2-Amino-4-trifluoromethoxybenzothiazole |
235101-36-7 |
C8H5F3N2OS |
 |
4-(3-クロロ-2-チエニル)-1,3-チアゾール-2-アミン |
339114-12-4 |
C7H5ClN2S2 |
 |
Metoprolol IMpurity 6 |
|
C15H25NO3 |
 |
Loratadine IMpurity D |
|
C22H23ClN2O2 |
 |
1,8-dibenzyl-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
267241-20-3 |
C24H37ClN4 |
 |
Lenvatinib Impurity 22 |
1528002-96-1 |
|
 |
2-Thiazolamine, 5-(4-cyclohexyl-1-piperazinyl)-4-(4,5-dichloro-2-thienyl)- |
570407-63-5 |
C17H22Cl2N4S2 |
 |
ethyl 3-(dimethylamino)-2-(4-methoxyphenyl)propanoate hydrochloride |
2174001-92-2 |
C14H22ClNO3 |
![1-[2-(2-クロロベンジルオキシ)-2-(2,4-ジクロロフェニル)エチル]-1H-イミダゾール](/CAS/20180808/GIF/47363-37-1.gif) |
1-[2-(2-クロロベンジルオキシ)-2-(2,4-ジクロロフェニル)エチル]-1H-イミダゾール |
47363-37-1 |
C18H15Cl3N2O |
 |
Dolutegravir 2-Desfluoro Impurity |
1863916-88-4 |
C20H20FN3O5 |
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzoic acid |
|
C18H22N4O4 |
 |
4'-(Difluoromethoxy)acetanilide |
22236-11-9 |
C9H9F2NO2 |
 |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
 |
6 beta-hydroxycortisol |
53-35-0 |
C21H30O6 |
![3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester](/CAS/20200515/GIF/100688-45-7.gif) |
3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester |
100688-45-7 |
C13H14O4 |
 |
Meropenem Impurity MAP-B |
|
|
 |
4-フェニル-1-(フェニルメチル)-4-ピペリジノール |
63843-83-4 |
C18H21NO |
![(2S)-2-[4-[2-(2,4-ジアミノ-6-プテリジニル)エチル]ベンゾイルアミノ]グルタル酸](/CAS/GIF/52454-37-2.gif) |
(2S)-2-[4-[2-(2,4-ジアミノ-6-プテリジニル)エチル]ベンゾイルアミノ]グルタル酸 |
52454-37-2 |
C20H21N7O5 |
 |
Brexpiprazole Impurity B |
|
|
![1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)-](/CAS/20211123/GIF/862260-38-6.gif) |
1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)- |
862260-38-6 |
C36H40FN2NaO5 |
 |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
 |
カフェイジン |
20041-90-1 |
C7H12N4O |
 |
cefditoren E-isomer(C=C) |
|
|
 |
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one |
2446799-72-8 |
C25H28N8O2 |
 |
Org198786-1 |
2412952-96-4 |
C71H114NNaO46S7 |
 |
Umeclidinium Bromide Impurity 8 |
869113-10-0 |
C27H30BrNO |
 |
methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate |
1421312-32-4 |
C17H13NO5 |
 |
(1R,2S,3S)-Aprepitant |
172822-28-5 |
C23H21F7N4O3 |
 |
1-(2-amino-4,5-dimethoxyphenyl)ethan-1-one |
1071574-51-0 |
C10H13NO3 |
 |
Rupatadine iMpurity D |
|
|
 |
HYDROXYZINE HYDROCHLORIDE |
|
C21H28Cl2N2O2 |
 |
Ticagrelor Impurity 138X |
|
|
![5-(5-(3-fluoro-4-(methylcarbamoyl)phenyl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-7-yl)-3-(trifluoromethyl)picolinamide](/) |
5-(5-(3-fluoro-4-(methylcarbamoyl)phenyl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-7-yl)-3-(trifluoromethyl)picolinamide |
|
|
![1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]-](/CAS/GIF/916975-92-3.gif) |
1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]- |
916975-92-3 |
C11H8F3N3O2 |
![3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/CAS/20210111/GIF/380918-53-6.gif) |
3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
380918-53-6 |
C23H15N3O |
 |
N-(4,6-dichloro-2-(propylthio)pyriMidin-5-yl)forMaMide |
1402150-28-0 |
C8H9Cl2N3OS |
 |
Canagliflozin Impurity 66 |
|
|
 |
(Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide |
|
|
 |
Levofloxacin Impurity 22 |
177472-29-6 |
C20H25F2N3O4 |
![N-[(1S,2S,4S)-4-(アセチルアミノ)-1-ベンジル-2-ヒドロキシ-5-フェニルペンチル]カルバミン酸1,3-チアゾール-5-イルメチル](/CAS/GIF/1010808-43-1.gif) |
N-[(1S,2S,4S)-4-(アセチルアミノ)-1-ベンジル-2-ヒドロキシ-5-フェニルペンチル]カルバミン酸1,3-チアゾール-5-イルメチル |
1010808-43-1 |
C25H29N3O4S |
 |
Aprepitant Impurity 6 |
170902-81-5 |
C23H21F7N4O3 |
 |
Tafluprost Impurity 15 |
|
|
 |
Flucloxacillin Impurity 3 |
|
|
 |
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- |
190728-24-6 |
C17H14N2O5 |
 |
Saxagliptin Impurity 34 |
2173146-31-9 |
C17H25NO5 |
![(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1)](/) |
(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1) |
|
|
 |
(S)-(-)-トルバプタン |
331947-44-5 |
C26H25ClN2O3 |
 |
Alogliptin Impurity 30 |
|
|
 |
Cefuroxime Impurity 2 |
|
C16H16N4O8S |
 |
Dasatinib Impurity D |
|
|
 |
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |